Derma Omnium

Derma Omnium (Laboratoires Derma Omnium) was a French specialty pharmaceutical company focused on the development and marketing of dermatological and dermo-cosmetic products. The company's flagship product line, Bio-Taches, utilized a proprietary active ingredient called Biotanoid to treat skin hyperpigmentation and melasma by inhibiting tyrosinase. In late 2007, Derma Omnium was acquired by Sinclair Pharma (now a subsidiary of Huadong Medicine) as part of a strategic expansion of Sinclair's dermatology portfolio. Other notable products in its range included Gen Ongles for nail health and Affina Lift for anti-aging. Today, the brand's legacy continues through the continued distribution of its core products under the Sinclair umbrella.